Xilinx's most recent trend suggests a bullish bias. One trading opportunity on Xilinx is a Bull Put Spread using a strike $126.00 short put and a strike $121.00 long put offers a potential 51.52% return on risk over the next 7 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $126.00 by expiration. The full premium credit of $1.70 would be kept by the premium seller. The risk of $3.30 would be incurred if the stock dropped below the $121.00 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Xilinx is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Xilinx is bullish.
The RSI indicator is at 61.7 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Xilinx
5G Stocks To Buy And Watch: Apple, Qualcomm, T-Mobile, Ericsson Gain Traction
Wed, 11 Nov 2020 12:15:55 +0000
The best 5G stocks to invest in will change over time. The consumer smartphone market will evolve into broader 5G wireless enterprise opportunities.
What a Biden Presidency Means for the Merger Boom
Tue, 10 Nov 2020 22:47:00 +0000
The change in administrations comes as mergers have pretty much rebounded since going on pause earlier in 2020 due to the Covid-19 pandemic.
Xilinx and Samsung Deliver Industry’s First Adaptable Computational Storage Drives
Tue, 10 Nov 2020 14:00:00 +0000
Xilinx and Samsung announced the availability of the Samsung SmartSSD® Computational Storage Drive (CSD).
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – CBMG, VRTU, MOBL, XLNX
Sat, 07 Nov 2020 19:40:00 +0000
NEW YORK, NY / ACCESSWIRE / November 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:Cellular Biomedicine Group, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, XLNX, HLIX, and LOAC Shareholders About Its Ongoing Investigations
Sat, 07 Nov 2020 03:12:00 +0000
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
Related Posts
Also on Market Tamer…
Follow Us on Facebook